1 |
Foy KC, Miller MJ, Moldovan N, Carson WE 3rd, Kaumaya PT. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. Oncoimmunology 2012;1:1048-60. [PMID: 23170253 DOI: 10.4161/onci.20708] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
|
2 |
Foy KC, Miller MJ, Moldovan N, Bozanovic T, Carson WE 3rd, Kaumaya PT. Immunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast cancer. Oncoimmunology 2012;1:1004-16. [PMID: 23170249 DOI: 10.4161/onci.21057] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
|
3 |
Kondasinghe TD, Saraha HY, Jackowski ST, Stockdill JL. Raising the Bar On-Bead: Efficient On-Resin Synthesis of α-Conotoxin LvIA. Tetrahedron Lett 2019;60:23-8. [PMID: 31564757 DOI: 10.1016/j.tetlet.2018.11.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
4 |
Arbour CA, Kondasinghe TD, Saraha HY, Vorlicek TL, Stockdill JL. Epimerization-free access to C-terminal cysteine peptide acids, carboxamides, secondary amides, and esters via complimentary strategies. Chem Sci 2018;9:350-5. [PMID: 29629104 DOI: 10.1039/c7sc03553e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 2.6] [Reference Citation Analysis]
|
5 |
Foy KC, Liu Z, Phillips G, Miller M, Kaumaya PT. Combination treatment with HER-2 and VEGF peptide mimics induces potent anti-tumor and anti-angiogenic responses in vitro and in vivo. J Biol Chem 2011;286:13626-37. [PMID: 21325276 DOI: 10.1074/jbc.M110.216820] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
|